Cargando…

Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results

PURPOSE: To present the functional and anatomic changes after intravitreal bevacizumab in eyes with macular edema (ME) due to branch retinal vein occlusion (BRVO). DESIGN: The study was a retrospective study. MATERIALS AND METHODS: The study included 31 patients with ME due to BRVO. We compared the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Demir, Mehmet, Oba, Ersin, Gulkilik, Gökhan, Odabasi, Mahmut, Ozdal, Erhan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130911/ https://www.ncbi.nlm.nih.gov/pubmed/21750607 http://dx.doi.org/10.2147/OPTH.S19279

Ejemplares similares

Comparison of the effects of intravitreal bevacizumab and triamcinolone acetonide in the treatment of macular edema secondary to central retinal vein occlusion
por: Demir, Mehmet, et al.
Publicado: (2014)

Intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusion: 12-month results
por: Thapa, Raba, et al.
Publicado: (2012)

Comparison Between Intravitreal Bevacizumab and Triamcinolone for Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Kim, Jin Young, et al.
Publicado: (2009)

The comparison of intravitreal triamcinolone and bevacizumab in patients with macular edema secondary to branch retinal vein occlusion
por: Gokce, Gokcen, et al.
Publicado: (2014)

Comparison of the Efficacy of Intravitreal Aflibercept and Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Wang, Jia-Kang, et al.
Publicado: (2016)

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion
por: Gutiérrez, Juan Carlos Mesa, et al.
Publicado: (2008)

Treatment of Branch Retinal Vein Occlusion induced Macular Edema with Bevacizumab
por: Abegg, Mathias, et al.
Publicado: (2008)

Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of Bevacizumab
por: Yunoki, Tatsuya, et al.
Publicado: (2013)

Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Lee, Kyou Ho, et al.
Publicado: (2017)

Intravitreal Bevacizumab Alone or Combined with Macular Laser Photocoagulation for Recurrent or Persistent Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Hirashima, Takafumi, et al.
Publicado: (2014)

Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab
por: Yalamanchi, Shalini, et al.
Publicado: (2011)

The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions
por: Ivanovska Adjievska, Biljana, et al.
Publicado: (2017)

Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion
por: Jaissle, Gesine B., et al.
Publicado: (2010)

Comparison of single injection and three monthly injections of intravitreal bevacizumab for macular edema associated with branch retinal vein occlusion
por: Ito, Yuka, et al.
Publicado: (2015)

Natural Short-term Course of Recurrent Macular Edema Following Intravitreal Bevacizumab Therapy in Branch Retinal Vein Occlusion
por: Yoo, Su Jin, et al.
Publicado: (2017)

OCT angiography features associated with macular edema recurrence after intravitreal bevacizumab treatment in branch retinal vein occlusion
por: Choi, Kwang-Eon, et al.
Publicado: (2019)

Comparison of Ranibizumab and Bevacizumab for Macular Edema Associated with Branch Retinal Vein Occlusion
por: Son, Bo Kwon, et al.
Publicado: (2017)

Intravitreal Bevacizumab May Increase Diabetic Macular Edema in Eyes with Attached Posterior Vitreous
por: Ozsutcu, Mustafa, et al.
Publicado: (2013)

Initial Dose of Three Monthly Intravitreal Injections versus PRN Intravitreal Injections of Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Ahn, Seong Joon, et al.
Publicado: (2013)

Long-term outcomes of intravitreous bevacizumab or tissue plasminogen activator or vitrectomy for macular edema due to branch retinal vein occlusion
por: Kumagai, Kazuyuki, et al.
Publicado: (2019)

Grid photocoagulation combined with intravitreal bevacizumab for recurrent macular edema associated with retinal vein occlusion
por: Ogino, Ken, et al.
Publicado: (2011)

Changes of retinal flow volume after intravitreal injection of bevacizumab in branch retinal vein occlusion with macular edema: a case series
por: Noma, Hidetaka, et al.
Publicado: (2016)

Foveal and parafoveal retinal thickness in healthy pregnant women in their last trimester
por: Demir, Mehmet, et al.
Publicado: (2011)

Short-term efficacy of intravitreal triamcinolone acetonide for macular edema secondary to retinal vein occlusion that is refractory to intravitreal bevacizumab
por: Yoo, Seul Gi, et al.
Publicado: (2015)

Intravitreal injection of conbercept combined with retinal photocoagulation on macular edema secondary to branch retinal vein occlusion
por: Wang, Bing, et al.
Publicado: (2020)

Effects of intravitreal bevacizumab on reduced visual acuity and macular thickness secondary to branch retinal vein occlusion
por: Eltutar, Kadir, et al.
Publicado: (2013)

Two-year outcomes of intravitreal bevacizumab therapy for macular oedema secondary to branch retinal vein occlusion
por: Hikichi, Taiichi, et al.
Publicado: (2014)

Rebound effect following intravitreal bevacizumab in branch retinal vein occlusion
por: Deka, Satyen, et al.
Publicado: (2009)

Efficacy of combined intravitreal bevacizumab and triamcinolone for branch retinal vein occlusion
por: Ali, Rasha I, et al.
Publicado: (2014)

Intravitreal bevacizumab upregulates transthyretin in experimental branch retinal vein occlusion
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2018)

Efficacy and visual prognostic factors of intravitreal bevacizumab as needed for macular edema secondary to central retinal vein occlusion
por: Hirose, Miki, et al.
Publicado: (2014)

Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema
por: Laine, Ilkka, et al.
Publicado: (2017)

Early versus Late Intravitreal Triamcinolone Acetonide for Macular Edema associated with Branch Retinal Vein Occlusion
por: Oh, Joo Youn, et al.
Publicado: (2007)

Comparison of Injection of Intravitreal Drugs with Standard Care in Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Lee, Kyungmin, et al.
Publicado: (2014)

A Real-Life Study: Intravitreal Aflibercept, Ranibizumab and Dexamethasone for Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Bayat, Alper Halil, et al.
Publicado: (2019)

Effects of Intravitreal Ranibizumab Injection on Peripheral Retinal Microcirculation and Cytokines in Branch Retinal Vein Occlusion with Macular Edema
por: Yasuda, Kanako, et al.
Publicado: (2023)

Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
por: Udaondo, Patricia, et al.
Publicado: (2011)

Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion
por: Paulose, Remya, et al.
Publicado: (2016)

Cytokines and the Pathogenesis of Macular Edema in Branch Retinal Vein Occlusion
por: Noma, Hidetaka, et al.
Publicado: (2019)

Oral Vitamin D Supplementation and Clinical Outcomes of Intravitreal Bevacizumab Injection for Macular Edema Secondary to Retinal Vein Occlusions
por: Karimi, Saeed, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_418thama32d7tiqivrj8bgj4cu